NE
Healthcare & Life Sciences
NeuroGenesis
United Stateswww.neurogenesis-cell.com/
NeuroGenesis is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About NeuroGenesis
Based in the United States, NeuroGenesis is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
NeuroGenesis develops proprietary autologous bone marrow stem cell therapies that deliver remyelinating and neuroregenerative proteins directly into the central nervous system to treat neurodegenerative diseases such as multiple sclerosis and ALS.
Explore NeuroGenesis's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.